Patrick O's most recent trade in Dream Finders Homes Inc - Ordinary Shares - Class A was a trade of 1,000,000 Prepaid Variable Forward Sale Contract done . Disclosure was reported to the exchange on March 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dream Finders Homes Inc (Class A) | Patrick O. Zalupski | Director, President and CEO, Ten Percent Owner | 16 Mar 2026 | 1,000,000 | 1,000,000 | - | - | Prepaid Variable Forward Sale Contract | ||
| Greenlight Cap Re Ltd (Class A) | Patrick O'Brien | Chief Operating Officer, SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2026 | 9,273 | 211,659 (0%) | 0% | 0 | ORDINARY SHARES | |
| Greenlight Cap Re Ltd (Class A) | Patrick O'Brien | Chief Operating Officer, SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 31,961 | 202,386 (0%) | 0% | 0 | ORDINARY SHARES | |
| AMC Networks Inc (Class A) | Patrick O’Connell | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2026 | 31,407 | 77,232 (0%) | 0% | - | AMC Networks Inc. Class A Common Stock | |
| AMC Networks Inc (Class A) | Patrick O’Connell | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2026 | 31,407 | 62,814 | - | - | Restricted Stock Units | |
| AMC Networks Inc (Class A) | Patrick O’Connell | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2026 | 19,305 | 52,784 (0%) | 0% | - | AMC Networks Inc. Class A Common Stock | |
| AMC Networks Inc (Class A) | Patrick O’Connell | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2026 | 19,305 | 19,305 | - | - | Restricted Stock Units | |
| AMC Networks Inc (Class A) | Patrick O’Connell | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.05 per share. | 09 Mar 2026 | 13,941 | 63,291 (0%) | 0% | 8.0 | 112,225 | AMC Networks Inc. Class A Common Stock |
| AMC Networks Inc (Class A) | Patrick O’Connell | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2026 | 11,856 | 37,753 (0%) | 0% | - | AMC Networks Inc. Class A Common Stock | |
| AMC Networks Inc (Class A) | Patrick O’Connell | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2026 | 11,856 | 0 | - | - | Restricted Stock Units | |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Sale of securities on an exchange or to another person at price $ 75.25 per share. | 09 Mar 2026 | 10,148 | 62,211 (0%) | 0% | 75.3 | 763,662 | Common Stock |
| AMC Networks Inc (Class A) | Patrick O’Connell | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.05 per share. | 09 Mar 2026 | 6,959 | 45,825 (0%) | 0% | 8.1 | 56,020 | AMC Networks Inc. Class A Common Stock |
| AMC Networks Inc (Class A) | Patrick O’Connell | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.05 per share. | 09 Mar 2026 | 4,274 | 33,479 (0%) | 0% | 8.1 | 34,406 | AMC Networks Inc. Class A Common Stock |
| Dream Finders Homes Inc (Class A) | Patrick O. Zalupski | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 287,119 | 2,158,591 | - | 0 | Class A common stock, par value $0.01 per share | |
| Dream Finders Homes Inc (Class A) | Patrick O. Zalupski | Director, President and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.71 per share. | 05 Mar 2026 | 48,348 | 2,092,819 | - | 15.7 | 759,547 | Class A common stock, par value $0.01 per share |
| Dream Finders Homes Inc (Class A) | Patrick O. Zalupski | Director, President and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.25 per share. | 05 Mar 2026 | 26,000 | 1,871,472 | - | 17.3 | 448,500 | Class A common stock, par value $0.01 per share |
| Dream Finders Homes Inc (Class A) | Patrick O. Zalupski | Director, President and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.40 per share. | 05 Mar 2026 | 17,424 | 2,141,167 | - | 16.4 | 285,754 | Class A common stock, par value $0.01 per share |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2026 | 9,543 | 11,466 (0%) | 0% | 0 | Common Stock | |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.40 per share. | 24 Feb 2026 | 4,049 | 7,417 (0%) | 0% | 21.4 | 86,649 | Common Stock |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2026 | 3,340 | 3,340 (0%) | 0% | 0 | Common Stock | |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2026 | 3,340 | 6,678 | - | - | Restricted Stock Units | |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.40 per share. | 24 Feb 2026 | 1,417 | 1,923 (0%) | 0% | 21.4 | 30,324 | Common Stock |
| Avidbank Holdings Inc | Patrick Timothy Oakes | EVP, CFO | Sale or transfer of securities back to the company at price $ 29.55 per share. | 24 Feb 2026 | 374 | 38,688 | - | 29.5 | 11,050 | Common Stock |
| Avidbank Holdings Inc | Patrick Timothy Oakes | EVP, CFO | Sale or transfer of securities back to the company at price $ 29.67 per share. | 23 Feb 2026 | 295 | 39,062 | - | 29.7 | 8,753 | Common Stock |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 20.54 per share. | 18 Feb 2026 | 45,500 | 44,615 (0%) | 0% | 20.5 | 934,570 | Common Stock |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 20.52 per share. | 18 Feb 2026 | 33,448 | 0 (0%) | 0% | 20.5 | 686,353 | Common Stock |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.10 per share. | 18 Feb 2026 | 21,075 | 65,690 (0%) | 0% | 18.1 | 381,458 | Common Stock |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2026 | 21,075 | 5,268 | - | - | Stock Option (right to buy) | |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2026 | 12,216 | 18,322 | - | - | Stock Option (right to buy) | |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.36 per share. | 18 Feb 2026 | 12,216 | 84,922 (0%) | 0% | 10.4 | 126,558 | Common Stock |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 20.55 per share. | 18 Feb 2026 | 11,167 | 33,448 (0%) | 0% | 20.6 | 229,482 | Common Stock |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2026 | 7,016 | 10,524 | - | - | Stock Option (right to buy) | |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.72 per share. | 18 Feb 2026 | 7,016 | 72,706 (0%) | 0% | 13.7 | 96,260 | Common Stock |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2026 | 5,193 | 20,772 | - | - | Stock Option (right to buy) | |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.76 per share. | 18 Feb 2026 | 5,193 | 90,115 (0%) | 0% | 11.8 | 61,070 | Common Stock |
| Avidbank Holdings Inc | Patrick Timothy Oakes | EVP, CFO | Sale or transfer of securities back to the company at price $ 30.00 per share. | 14 Feb 2026 | 296 | 39,357 | - | 30 | 8,880 | Common Stock |
| Avidbank Holdings Inc | Patrick Timothy Oakes | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2026 | 2,720 | 39,653 | - | 0 | Common Stock | |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 11,991 | 78,162 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Sale of securities on an exchange or to another person at price $ 83.53 per share. | 29 Jan 2026 | 6,179 | 71,983 (0%) | 0% | 83.5 | 516,153 | Common Stock |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 25,800 | 90,601 | - | - | Performance Restricted Stock Units | |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 21,473 | 75,362 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 21,473 | 39,251 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 9,675 | 48,926 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Sale of securities on an exchange or to another person at price $ 75.84 per share. | 15 Jan 2026 | 9,191 | 66,171 (0%) | 0% | 75.8 | 697,045 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 75,000 | 547,408 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2026 | 540 | 473,828 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2026 | 540 | 473,288 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2026 | 540 | 474,368 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2026 | 440 | 472,848 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2026 | 440 | 472,408 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 19,350 | 19,350 | - | - | Non-Qualified Stock Option (right to buy) | |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 18,852 | 18,852 | - | - | Restricted Stock Units | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 62.96 per share. | 31 Dec 2025 | 13,451 | 500,418 (0%) | 0% | 63.0 | 846,875 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 63.84 per share. | 31 Dec 2025 | 11,842 | 488,576 (0%) | 0% | 63.8 | 755,993 | Common Stock |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 31 Dec 2025 | 6,822 | 44,615 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 62.23 per share. | 31 Dec 2025 | 6,164 | 513,869 (0%) | 0% | 62.2 | 383,586 | Common Stock |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 5,970 | 46,064 (0%) | 0% | 0 | Common Stock | |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 5,970 | 17,911 | - | - | Restricted Stock Units | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 62.91 per share. | 31 Dec 2025 | 5,873 | 477,290 (0%) | 0% | 62.9 | 369,470 | Common Stock |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 5,373 | 51,437 (0%) | 0% | 0 | Common Stock | |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 5,373 | 21,489 | - | - | Restricted Stock Units | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 61.20 per share. | 31 Dec 2025 | 4,368 | 520,033 (0%) | 0% | 61.2 | 267,322 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 64.44 per share. | 31 Dec 2025 | 2,700 | 485,876 (0%) | 0% | 64.4 | 173,988 | Common Stock |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 2,363 | 40,094 (0%) | 0% | 0 | Common Stock | |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 2,363 | 2,363 | - | - | Restricted Stock Units | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 64.04 per share. | 31 Dec 2025 | 2,336 | 474,954 (0%) | 0% | 64.0 | 149,597 | Common Stock |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 9.88 per share. | 31 Dec 2025 | 2,145 | 36,233 (0%) | 0% | 9.9 | 21,193 | Common Stock |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 1,498 | 37,731 (0%) | 0% | 0 | Common Stock | |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 1,498 | 0 | - | - | Restricted Stock Units | |
| Healthcare Services Grp Inc | Patrick J. Orr | EVP & Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 1,444 | 10,867 | - | - | Phantom Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 66.01 per share. | 31 Dec 2025 | 900 | 484,976 (0%) | 0% | 66.0 | 59,409 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 62.25 per share. | 31 Dec 2025 | 900 | 483,163 (0%) | 0% | 62.3 | 56,025 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 61.12 per share. | 31 Dec 2025 | 600 | 484,063 (0%) | 0% | 61.1 | 36,672 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 560 | 526,641 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 560 | 524,401 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 560 | 524,961 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 560 | 525,521 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2025 | 560 | 526,081 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 68.00 per share. | 31 Dec 2025 | 313 | 484,663 (0%) | 0% | 68 | 21,284 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Sale of securities on an exchange or to another person at price $ 68.00 per share. | 31 Dec 2025 | 46 | 474,908 (0%) | 0% | 68 | 3,128 | Common Stock |
| Treehouse Foods Inc | Patrick M. O’Donnell | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 6,250 | 12,500 | - | - | Restricted Stock Unit | |
| Treehouse Foods Inc | Patrick M. O’Donnell | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 6,250 | 25,814 (0%) | 0% | 0 | Common Stock | |
| Treehouse Foods Inc | Patrick M. O’Donnell | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 5,307 | 21,119 (0%) | 0% | 0 | Common Stock | |
| Treehouse Foods Inc | Patrick M. O’Donnell | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 5,307 | 5,307 | - | - | Restricted Stock Unit | |
| Treehouse Foods Inc | Patrick M. O’Donnell | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.60 per share. | 19 Dec 2025 | 1,832 | 23,982 (0%) | 0% | 23.6 | 43,235 | Common Stock |
| Treehouse Foods Inc | Patrick M. O’Donnell | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.60 per share. | 19 Dec 2025 | 1,555 | 19,564 (0%) | 0% | 23.6 | 36,698 | Common Stock |
| Treehouse Foods Inc | Patrick M. O’Donnell | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 749 | 0 | - | - | Restricted Stock Unit | |
| Treehouse Foods Inc | Patrick M. O’Donnell | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 749 | 24,731 (0%) | 0% | 0 | Common Stock | |
| Treehouse Foods Inc | Patrick M. O’Donnell | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.60 per share. | 19 Dec 2025 | 220 | 24,511 (0%) | 0% | 23.6 | 5,192 | Common Stock |
| Cineverse Corp (Class A) | Patrick O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 32,413 | 160,906 (0%) | 0% | 0 | Class A Common Stock | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 31.17 per share. | 19 Nov 2025 | 562 | 118,963 (0%) | 0% | 31.2 | 17,518 | Common Stock |
| Avidbank Holdings Inc | Patrick Timothy Oakes | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2025 | 2,155 | 36,933 | - | 0 | Common Stock | |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.87 per share. | 06 Oct 2025 | 10,200 | 67,330 (0%) | 0% | 52.9 | 539,274 | Common Stock |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Sale of securities on an exchange or to another person at price $ 69.89 per share. | 06 Oct 2025 | 10,200 | 57,130 (0%) | 0% | 69.9 | 712,849 | Common Stock |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2025 | 10,200 | 17,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Sale of securities on an exchange or to another person at price $ 69.27 per share. | 06 Oct 2025 | 3,241 | 53,889 (0%) | 0% | 69.3 | 224,488 | Common Stock |
| Ionis Pharma Inc | R. Patrick O'Neil | EVP CLO & General Counsel | Sale of securities on an exchange or to another person at price $ 67.69 per share. | 02 Oct 2025 | 34,461 | 57,130 (0%) | 0% | 67.7 | 2,332,638 | Common Stock |
| Ionis Pharma Inc | Patrick O'Neil R. | EVP CLO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2025 | 34,461 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | R. Patrick O'Neil | EVP CLO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.89 per share. | 02 Oct 2025 | 34,461 | 91,591 (0%) | 0% | 60.9 | 2,098,330 | Common Stock |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Sale of securities on an exchange or to another person at price $ 67.69 per share. | 02 Oct 2025 | 30,203 | 57,130 (0%) | 0% | 67.7 | 2,044,417 | Common Stock |
| Ionis Pharma Inc | O'Neil R. Patrick | EVP CLO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2025 | 30,203 | 0 | - | - | Non-Qualified Stock Option (right to buy) |